Literature DB >> 12161607

Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer families.

N D Kauff, P Perez-Segura, M E Robson, L Scheuer, B Siegel, A Schluger, B Rapaport, T S Frank, K Nafa, N A Ellis, G Parmigiani, K Offit.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12161607      PMCID： PMC1735198          DOI： 10.1136/jmg.39.8.611

Source DB:  PubMed          Journal:  J Med Genet        ISSN： 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  28 in total

Review 1.  Population genetic testing for cancer susceptibility: founder mutations to genomes.

Authors:  William D Foulkes; Bartha Maria Knoppers; Clare Turnbull
Journal:  Nat Rev Clin Oncol       Date:  2015-10-20       Impact factor: 66.675

2.  Ashkenazi Jews and breast cancer: the consequences of linking ethnic identity to genetic disease.

Authors:  Sherry I Brandt-Rauf; Victoria H Raveis; Nathan F Drummond; Jill A Conte; Sheila M Rothman
Journal:  Am J Public Health       Date:  2006-10-03       Impact factor: 9.308

3.  Accuracy of BRCA1 and BRCA2 founder mutation analysis in formalin-fixed and paraffin-embedded (FFPE) tissue.

Authors:  M A Adank; E Brogi; F Bogomolniy; E A Wadsworth; K J Lafaro; C J Yee; T Kirchhoff; E J Meijers-Heijboer; N D Kauff; J Boyd; K Offit
Journal:  Fam Cancer       Date:  2006-05-25       Impact factor: 2.375

4.  Cancer Susceptibility Genetic Testing in a High-Risk Cohort of Urban Ashkenazi Jewish Individuals.

Authors:  Sarah M Nielsen; Lenika M De Simone; Olufunmilayo I Olopade
Journal:  J Genet Couns       Date:  2018-06-26       Impact factor: 2.537

5.  The role of testing for BRCA1 and BRCA2 mutations in cancer prevention.

Authors:  Anne Marie McCarthy; Katrina Armstrong
Journal:  JAMA Intern Med       Date:  2014-07       Impact factor: 21.873

6.  To reflex or not: additional BRCA1/2 testing in Ashkenazi Jewish individuals without founder mutations.

Authors:  Nancie Petrucelli; Sarah Mange; Jennifer L Fulbright; Lindsay Dohany; Dana Zakalik; Debra Duquette
Journal:  J Genet Couns       Date:  2014-09-09       Impact factor: 2.537

7.  Genotype-Phenotype Correlations by Ethnicity and Mutation Location in BRCA Mutation Carriers.

Authors:  Soley Bayraktar; Michelle Jackson; Angelica M Gutierrez-Barrera; Diane Liu; Funda Meric-Bernstam; Amanda Brandt; Ashley Woodson; Jennifer Litton; Karen H Lu; Vicente Valero; Banu K Arun
Journal:  Breast J       Date:  2015-03-19       Impact factor: 2.431

8.  Detection of BRCA1 and BRCA2 Ashkenazi Jewish founder mutations in formalin-fixed paraffin-embedded tissues using conventional PCR and heteroduplex/amplicon size differences.

Authors:  Kathy A Mangold; Vivien Wang; Scott M Weissman; Wendy S Rubinstein; Karen L Kaul
Journal:  J Mol Diagn       Date:  2009-12-03       Impact factor: 5.568

9.  Offspring gender ratio and the rate of recurrent spontaneous miscarriages in jewish women at high risk for breast/ovarian cancer.

Authors:  Inbar Gal; Siegal Sadetzki; Ruth Gershoni-Baruch; Bernice Oberman; Howard Carp; Moshe Z Papa; Tal Diestelman-Menachem; Shlomit Eisenberg-Barzilai; Eitan Friedman
Journal:  Am J Hum Genet       Date:  2004-04-28       Impact factor: 11.025

10.  The relative contribution of point mutations and genomic rearrangements in BRCA1 and BRCA2 in high-risk breast cancer families.

Authors:  Maurizia Dalla Palma; Susan M Domchek; Jill Stopfer; Julie Erlichman; Jill D Siegfried; Jessica Tigges-Cardwell; Bernard A Mason; Timothy R Rebbeck; Katherine L Nathanson
Journal:  Cancer Res       Date:  2008-08-14       Impact factor: 12.701
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.